TY - JOUR
T1 - Opportunistic infections
AU - Powderly, William G.
PY - 1996/5/7
Y1 - 1996/5/7
N2 - Prophylaxis for Pneumocystis carinii has been standard care in HIV therapeutics for almost a decade. This year saw the results of clinical trials demonstrating effective prophylaxis for most of the main HIV-related opportunistic infections, systemic fungal, Mycobacterium avium complex and cytomegalovirus. However, in spite of effectiveness, it is unclear that survival is prolonged, and multiple prophylaxis is complicated by increased toxicity, drug-drug interactions, microbial resistance and cost.
AB - Prophylaxis for Pneumocystis carinii has been standard care in HIV therapeutics for almost a decade. This year saw the results of clinical trials demonstrating effective prophylaxis for most of the main HIV-related opportunistic infections, systemic fungal, Mycobacterium avium complex and cytomegalovirus. However, in spite of effectiveness, it is unclear that survival is prolonged, and multiple prophylaxis is complicated by increased toxicity, drug-drug interactions, microbial resistance and cost.
UR - http://www.scopus.com/inward/record.url?scp=0029939128&partnerID=8YFLogxK
U2 - 10.1097/00001432-199602000-00006
DO - 10.1097/00001432-199602000-00006
M3 - Short survey
AN - SCOPUS:0029939128
VL - 9
SP - 23
EP - 27
JO - Current Opinion in Infectious Diseases
JF - Current Opinion in Infectious Diseases
SN - 0951-7375
IS - 1
ER -